|
|
Volumn 15 Suppl 5, Issue , 2010, Pages 29-38
|
|
A new look at node-negative breast cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
TUMOR MARKER;
UROKINASE;
ADJUVANT CHEMOTHERAPY;
ARTICLE;
BREAST TUMOR;
CANCER STAGING;
FEMALE;
HUMAN;
META ANALYSIS (TOPIC);
METABOLISM;
METHODOLOGY;
MULTICENTER STUDY (TOPIC);
PATIENT SELECTION;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RISK ASSESSMENT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
FEMALE;
HUMANS;
META-ANALYSIS AS TOPIC;
MULTICENTER STUDIES AS TOPIC;
NEOPLASM STAGING;
PATIENT SELECTION;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK ASSESSMENT;
TUMOR MARKERS, BIOLOGICAL;
UROKINASE-TYPE PLASMINOGEN ACTIVATOR;
|
|
EID: 79952654337
PISSN: None
EISSN: 1549490X
Source Type: Journal
DOI: 10.1634/theoncologist.2010-S5-29 Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
